DEA Classifies Tramadol a Controlled Substance

Posted in Latest News on September 10, 2014.

Under a final rule published in the Federal Register, the pain reliever tramadol is classified as a Schedule IV controlled substance (CS) starting August 18, 2014. Drug Enforcement Administration (DEA) will require manufacturers to print the “C-IV” designation on all labels that contain tramadol, including its salts, isomers, and salts of isomers.



More Latest News

Important notice regarding Rhopressa
February 12, 2019

The board approved Rhopressa (netarsudil ophthalmic solution) 0.02% for addition to Rule 64B13-18.002. Effective January 25, 2019, Licensees are now permitted to prescribe Rhopressa. Continue reading


Florida Jurisprudence CE Requirement
February 11, 2019

The Board of Optometry voted to waive the 2-hour Florida Jurisprudence requirement for all out-of-state licensees for the current biennium only. Click Here for more information. Continue reading